Cardiomyopathy Trial, Recruiting NCT06360939 Sponsor: Western Sydney Local Health District Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06360939
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a structural heart condition — such as a heart affected by blocked arteries, a weakened heart muscle, or a heart defect present from birth — where heart scans or tests show abnormal heart wall movement, thickened heart muscle, or scarring in the heart.
  • People who have had a recurring specific type of dangerous heart rhythm called monomorphic ventricular tachycardia (VT), which means at least one episode treated by a defibrillator device (ICD), or a VT episode lasting more than 30 seconds, or a VT episode triggered during a specialised heart electrical test.
  • People who score 9 or more on a medical risk tool called the PAINESD score, or who are assessed as being at least moderately at risk of VT returning or of death based on another tool called the I-VT score — both are established tools doctors use to identify people at higher risk after a heart procedure (confirm with trial site).

Who may not be able to join:

  • People under 18 years of age.
  • People whose life expectancy is estimated to be less than 3 months.
  • People for whom a heart catheter ablation procedure has been assessed by a heart rhythm specialist as being unlikely to help or as carrying too high a risk.
  • People who are unwilling or unable to give their consent to participate.
  • People known to have inherited heart electrical conditions such as CPVT, long or short QT syndrome, or Brugada syndrome.
  • People for whom radiation therapy has been assessed as unsuitable or unsafe by their treating doctors.
  • People who are pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (02)88908140

Australian sites

Westmead Hospital, Westmead,
02 8890 8140

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Western Sydney Local Health District
Registry
ClinicalTrials.gov
Start date
3 November 2025
Est. completion
20 June 2026

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

VT burden

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov